Zobrazeno 1 - 10
of 431
pro vyhledávání: '"E, Anaissie"'
Autor:
L JONESJACKSON, R WALKER, G PURNELL, S MCLAREN, R SKINNER, J THOMAS, L SUVA, E ANAISSIE, M MICELI, C NELSON
Publikováno v:
Journal of Orthopaedic Research. 23:1484-1489
Autor:
Rammurti T. Kamble, Carla S. Wilson, DS Siegel, B. Barlogie, E Anaissie, G Tricot, P Anderson, A. Fassas, R Desikan, JR Sawyer
Publikováno v:
Leukemia & Lymphoma. 46:1137-1142
Malignant pleural effusion (MPE) in multiple myeloma (MM) is rare. Approximately 80 cases have been reported. To delineate optimal treatment and prognostic variables in these patients, we reviewed 11 MM patients with MPE. MPE developed at median of 1
Autor:
T Lahoutte, C Vanhove, V Caveliers, M Defrise, H Everaert, A Bossuyt, P. R. Franken, K. P. Schäfers, M. Kriens, C. Barnard, O. Schober, M. Schäfers, K Kopka, S Wagner, MP Law, B Riemann, VW Pike, P Herrero, CS Dence, Z Kisrieva-Ware, P Eisenbeis, MJ Welch, RJ Gropler, J Bucerius, AY Joe, J Schmaliohann, D Gündisch, MJ Reinhardt, H-J Biersack, U Wüllner, DF Ranney, RM Peshock, GG McDonald, PJ Slomka, RA deKemp, RSB Beanlands, H Nishina, A Abidov, DS Berman, G Germano, LM Riou, AR Goode, K Hatada, M Ruiz, R Lima, TD Harris, GA Beller, DK Glover, H Kim, MH Miceli, D Delbeke, P Bhargava, LB Jones Jackson, RC Walker, E Anaissie, A Alavi, SM Hanrahan, M Janabi, SE Taylor, JJ Rychak, AL Klibanov, A Leppanen, RD Cummings, K Ley, J Hossack, AI Veress, B Feng, Y Yang, JA Weiss, RH Huesman, GT Gullberg, TL Sharp, JA Englebach, NM Fettig, LW Dobrucki, J Hua, BN Bourke, MM Sadeghi, P Cavaliere, M Mendizabal, N VanRoyen, IR Buschmann, AJ Sinusas, J Zhang, HR Fassaei, S Krassilnikova, L Esmailzadeh, AA Gharaei, A Kooshkabadi, DS Edwards, P Yalamanchili, BL Zaret, JR Bender, FH Epstein, WD Gilson, FC Sureau, Z Yang, BA French, S Lewis, XE Lu, EM Tom, MM Felix, JE Gretton, RP Varghese, WR Wagner, FS Villanueva
Publikováno v:
Journal of Nuclear Cardiology. 11:367-373
Autor:
A, Badros, B, Barlogie, C, Morris, R, Desikan, S R, Martin, N, Munshi, M, Zangari, J, Mehta, A, Toor, M, Cottler-Fox, A, Fassas, E, Anaissie, S, Schichman, G, Tricot, E, Aniassie
Publikováno v:
Blood. 97:2574-2579
Standard allogeneic stem cell transplant (allo-SCT) regimens have been associated with a high transplant-related mortality (TRM) in multiple myeloma (MM). Nonmyeloablative therapy can establish stable engraftment after allo-SCT and maintain the antit
Autor:
A. Fothergill, Ana Espinel-Ingroff, B Breslin, J Peter, M Pfaller, M G Rinaldi, V Paetznick, E Anaissie, D. M. Dixon, K Dawson
Publikováno v:
Antimicrobial Agents and Chemotherapy. 39:314-319
The purpose of the study was to evaluate the interlaboratory agreement of broth dilution susceptibility methods for five species of conidium-forming (size range, 2 to 7 microns) filamentous fungi. The methods used included both macro- and microdiluti
Publikováno v:
Medical Mycology. 32:33-51
Autor:
D, Neofytos, J A, Fishman, D, Horn, E, Anaissie, C-H, Chang, A, Olyaei, M, Pfaller, W J, Steinbach, K M, Webster, K A, Marr
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 12(3)
Contemporary epidemiology and outcomes of invasive fungal infections (IFIs) in solid organ transplant (SOT) recipients are not well described. From March 2004 through September 2007, proven and probable IFIs were prospectively identified in 17 transp
Publikováno v:
Blood. 79:876-881
Thirty-four adults with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside (ara-C) 3 g/m2 intravenously over 2 hours every 12 hours for six dose
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A, Badros, B, Barlogie, E, Siegel, C, Morris, R, Desikan, M, Zangari, A, Fassas, E, Anaissie, N, Munshi, G, Tricot
Publikováno v:
British journal of haematology. 114(3)
The feasibility and efficacy of autologous stem cell transplantation (auto-SCT) in patients agedor = 70 years was analysed. Newly diagnosed (n = 34) and refractory multiple myeloma (n = 36) patients were studied. The median age was 72 years (range: 7